Treatment approaches and outcomes of a head and neck lymphedema service at an Australian comprehensive cancer center.
exercise
head and neck cancer
lymphedema
self-management
supportive care
Journal
Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541
Informations de publication
Date de publication:
06 2023
06 2023
Historique:
revised:
22
01
2023
received:
04
09
2022
accepted:
30
03
2023
medline:
12
5
2023
pubmed:
18
4
2023
entrez:
17
4
2023
Statut:
ppublish
Résumé
Patients treated for head and neck cancer are at high risk of developing head and neck lymphedema (HNL). We describe outcomes of HNL management at an Australian institution from 2018 to 2020. Electronic records from Chris O'Brien Lifehouse were retrospectively reviewed from January 1, 2018 to December 31, 2020. Objective changes in HNL were assessed using The M. D. Anderson Cancer Center (MDACC) HNL rating scale and Assessment of Lymphedema of the Head and Neck (ALOHA). Among the 100 patients referred for management of HNL, surgery was the most frequent treatment modality (80%; 70% with neck dissection) and 69% underwent radiotherapy. Manual lymphatic drainage (MLD) was most often prescribed (96%), followed by self-MLD (93%). Small but significant improvements in ALOHA measurements were observed for 50 patients (50%). Only 5/29 (17%) patients had post-treatment improvements on the MDACC scale. Standardized, prospective measurement of treatment approaches and outcomes is needed to further evaluate the service.
Sections du résumé
BACKGROUND
Patients treated for head and neck cancer are at high risk of developing head and neck lymphedema (HNL). We describe outcomes of HNL management at an Australian institution from 2018 to 2020.
METHODS
Electronic records from Chris O'Brien Lifehouse were retrospectively reviewed from January 1, 2018 to December 31, 2020. Objective changes in HNL were assessed using The M. D. Anderson Cancer Center (MDACC) HNL rating scale and Assessment of Lymphedema of the Head and Neck (ALOHA).
RESULTS
Among the 100 patients referred for management of HNL, surgery was the most frequent treatment modality (80%; 70% with neck dissection) and 69% underwent radiotherapy. Manual lymphatic drainage (MLD) was most often prescribed (96%), followed by self-MLD (93%). Small but significant improvements in ALOHA measurements were observed for 50 patients (50%). Only 5/29 (17%) patients had post-treatment improvements on the MDACC scale.
CONCLUSIONS
Standardized, prospective measurement of treatment approaches and outcomes is needed to further evaluate the service.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1539-1548Informations de copyright
© 2023 The Authors. Head & Neck published by Wiley Periodicals LLC.
Références
Executive Committee. The diagnosis and treatment of peripheral lymphedema: 2016 consensus document of the international society of lymphology. Lymphology. 2016;49:170-184.
Smith BG, Lewin JS. Lymphedema management in head and neck cancer. Curr Opin Otolaryngol Head Neck Surg. 2010;18:153-158.
Murphy BA, Deng J. Advances in supportive care for late effects of head and neck cancer. J Clin Oncol. 2015;33:3314-3321.
Ringash J. Survivorship and quality of life in head and neck cancer. J Clin Oncol. 2015;33:3322-3327.
Ridner SH, Dietrich MS, Niermann K, Cmelak A, Mannion K, Murphy B. A prospective study of the lymphedema and fibrosis continuum in patients with head and neck cancer. Lymphat Res Biol. 2016;14:198-205.
Jeans C, Ward EC, Brown B, et al. Association between external and internal lymphedema and chronic dysphagia following head and neck cancer treatment. Head Neck. 2021;43:255-267.
Jeans C, Ward EC, Cartmill B, et al. Patient perceptions of living with head and neck lymphoedema and the impacts to swallowing, voice and speech function. Eur J Cancer Care (Engl). 2019;28:e12894.
Smith BG, Hutcheson KA, Little LG, et al. Lymphedema outcomes in patients with head and neck cancer. Otolaryngol Head Neck Surg. 2015;152:284-291.
Doersam JK, Dietrich MS, Adair MA, Rhoten B, Deng J, Ridner SH. A comparison of symptoms among patients with head and neck or truncal lymphedema and normal controls. Lymphat Res Biol. 2019;17:661-670.
Deng J, Sinard RJ, Murphy B. Patient experience of head and neck lymphedema therapy: a qualitative study. Support Care Cancer. 2019;27:1811-1823.
Jeans C, Brown B, Ward EC, et al. Comparing the prevalence, location, and severity of head and neck lymphedema after postoperative radiotherapy for oral cavity cancers and definitive chemoradiotherapy for oropharyngeal, laryngeal, and hypopharyngeal cancers. Head Neck. 2020;42:3364-3374.
Melissant HC, Jansen F, Eerenstein SE, et al. Body image distress in head and neck cancer patients: What are we looking at? Support Care Cancer. 2021;29:2161-2169.
Dahill A, Al-Nakishbandi H, Cunningham KB, Humphris GM, Lowe D, Rogers SN. Loneliness and quality of life after head and neck cancer. Br J Oral Maxillofac Surg. 2020;58:959-965.
North AS, Carson L, Sharp L, Patterson J, Hamilton DW. The unmet needs of patients with advanced incurable head and neck cancer and their carers: a systematic review and meta-ethnography of qualitative data. Eur J Cancer Care. 2021;30:e13474.
Deng J, Ridner SH, Dietrich MS, et al. Prevalence of secondary lymphedema in patients with head and neck cancer. J Pain Symptom Manage. 2012;43:244-252.
McGarvey AC, Osmotherly PG, Hoffman GR, Chiarelli PE. Lymphoedema following treatment for head and neck cancer: impact on patients, and beliefs of health professionals. Eur J Cancer Care (Engl). 2014;23:317-327.
Lymphoedema Framework. Best Practice for the Management of Lymphoedema. International Consensus. MEP Ltd; 2006.
Deng J, Ridner SH, Murphy BA. Lymphedema in patients with head and neck cancer. Oncol Nurs Forum. 2011;38:E1-E10.
Australasian Lymphology Association. Position Paper: Early Detection of Breast Cancer-Related Lymphoedema. ALA; 2019.
Australasian Lymphology Association. Position Paper: The Use of Compression in the Management of Lymphoedema. ALA; 2019.
RianCorp. Low level laser therapy (LLLT); 2022.
LymphaTouch. LymphaTouch Product LT01; 2022.
Purcell A. Head and neck lymphoedema management practices. J Lymphoedema. 2013;8:8-15.
Purcell A, Nixon J, Fleming J, McCann A, Porceddu S. Measuring head and neck lymphedema: the “ALOHA” trial. Head Neck. 2016;38:79-84.
NSW Agency for Clinical Innovation. Lymphoedema: A Guide for Clinical Services. ACI; 2018.
Pigott A, Nixon J, Fleming J, Porceddu S. Head and neck lymphedema management: evaluation of a therapy program. Head Neck. 2018;40:1131-1137.
Pigott A, Brown B, Trevethan M, et al. Head and neck lymphoedema-research challenges during the COVID-19 pandemic. Br J Community Nurs. 2021;26:S6-S15.
McLaughlin TM, Broadhurst JJ, Harris CJ, McGarry S, Keesing SL. A randomized pilot study on self-management in head and neck lymphedema. Laryngosc Invest Otolaryngol. 2020;5:879-889.
Ostby PL, Armer JM. Complexities of adherence and post-cancer lymphedema management. J Pers Med. 2015;5:370-388.
Jackson LK, Ridner SH, Deng J, et al. Internal lymphedema correlates with subjective and objective measures of dysphagia in Head and neck cancer patients. J Palliat Med. 2016;19:949-956.
Deng J, Murphy B, Dietrich MS, Bartow C, Adcock D, Moore A. Effects of Manual Lymph Drainage on Lymphoedema and Dysphagia in Head and Neck Cancer: A Case Series. Wounds International; 2019:22-26.
Delfin Technologies. LymphScanner; 2022.
American Head & Neck Society. Lymphedema. AHNS; 2022.
Suami H, Heydon-White A, Mackie H, Czerniec S, Koelmeyer L, Boyages J. A new indocyanine green fluorescence lymphography protocol for identification of the lymphatic drainage pathway for patients with breast cancer-related lymphoedema. BMC Cancer. 2019;19:985.
Gutiérrez C, Mayrovitz HN, Naqvi SHS, Karni RJ. Longitudinal effects of a novel advanced pneumatic compression device on patient-reported outcomes in the management of cancer-related head and neck lymphedema: a preliminary report. Head Neck. 2020;42:1791-1799.
Mayrovitz HN, Ryan S, Hartman JM. Usability of advanced pneumatic compression to treat cancer-related head and neck lymphedema: a feasibility study. Head Neck. 2018;40:137-143.
Ridner SH, Dietrich MS, Deng J, Ettema SL, Murphy B. Advanced pneumatic compression for treatment of lymphedema of the head and neck: a randomized wait-list controlled trial. Support Care Cancer. 2021;29:795-803.
Gutierrez C, Karni RJ, Naqvi S, et al. Head and neck lymphedema: treatment response to single and multiple sessions of advanced pneumatic compression therapy. Otolaryngol Head Neck Surg. 2019;160:622-626.